OPKO Health Inc OPK:NASDAQ

Last Price$2.04NASDAQ Previous Close - Last Trade as of 4:00PM ET 10/14/19

Today's Change-0.01(0.49%)
Bid (Size)$2.01 (200)
Ask (Size)$2.05 (5)
Day Low / High$2.00 - 2.09
Volume2.4 M
 

View Biotechnology IndustryPeer Comparison as of 10/14/2019

 

OPKO Health Inc ( NASDAQ )

Price: $2.04
Change: -0.01 (0.49%)
Volume: 2.4 M
4:00PM ET 10/14/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Coherus BioSciences Inc ( NASDAQ )

Price: $17.99
Change: 0.00 (0.00%)
Volume: 886.8 K
3:59PM ET 10/14/2019
 
 

Veracyte Inc ( NASDAQ )

Price: $25.22
Change: -0.08 (0.32%)
Volume: 731.6 K
4:00PM ET 10/14/2019
 
 

Audentes Therapeutics Inc ( NASDAQ )

Price: $27.44
Change: +0.03 (0.11%)
Volume: 422.1 K
3:59PM ET 10/14/2019
 

Read more news Recent News

Close Update: US Stocks Close Mixed as Better US PMI Figures Push Back Concerns Over Global Growth Slowdown
4:39PM ET 9/23/2019 MT Newswires

US stocks closed mixed Monday, losing the modest gains secured during midday as investors digested downbeat results of a closely watched survey for the...

Opko Health Says Growth Hormone Deficiency Treatment Shows Favorable Safety Profile After Four Years of Testing
2:46PM ET 9/23/2019 MT Newswires

Shares of Opko Health, Inc. (OPK) were almost 5% higher after the company said its Somatrogon treatment demonstrated a "favorable" safety profile and...

Opko Health Completes Phase 3 Study For Investigational Growth Hormone Deficiency Treatment
12:59PM ET 8/29/2019 MT Newswires

Opko Health (OPK) said Thursday that it has completed the pivotal phase-three study on its investigational somatrogon drug that's used to treat growth...

--Analyst Actions: OPKO Health's Price Target Cut to $4 From $5 at Barrington, Outperform Rating Reiterated
11:17AM ET 8/08/2019 MT Newswires

Price: 1.95, Change: -0.01, Percent Change: -0.26 ...

View all Commentary and Analysis

OPKO Health, Inc. (OPK) CEO Phillip Frost on Q2 2019 Results - Earnings Call Transcript
9:31PM ET 8/07/2019 Seeking Alpha

Insider Weekends: Tracy Krohn Buys Shares Of W&T Offshore
11:55AM ET 7/23/2019 Seeking Alpha

Daily Insider Ratings Round Up 7/17/19
6:38AM ET 7/19/2019 Seeking Alpha

Daily Insider Ratings Round Up 7/15/19
11:30AM ET 7/17/2019 Seeking Alpha

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Phone+1.305.575.4100
Number of Employees5,690
Recent SEC Filing10/02/2019SC 13D/A
Chairman & Chief Executive OfficerPhillip Frost
Vice Chairman & Chief Technical OfficerJane H. Hsiao
Director & Executive Vice President-AdministrationSteven D. Rubin
Chief Executive Officer-OPKO RenalCharles W. Bishop

Company Highlights

Price Open$2.05
Previous Close$2.05
52 Week Range$1.73 - 3.94
Market Capitalization$1.3 B
Shares Outstanding615.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/08/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.39
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-26.54%
Return on Equity-13.86%

Analyst Ratings as of 03/14/2019

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset